Coya Therapeutics, Inc. (COYA) Tops Q1 EPS by 37c
Tweet
Share
E-mailGet Alerts COYA Hot Sheet
Join SI Premium – FREE
Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q1 EPS of ($0.32), $0.37 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $251.15 million.
For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- Stifel Starts Tower Semiconductor (TSEM) at Buy, Top Pick
- Hyperscale Data reports blockchain revenue surge in Q2 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
